Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Change in Acquisitions & Divestments: 2020-2021

Historic Change in Acquisitions & Divestments for Black Diamond Therapeutics (BDTX) over the last 1 years, with Dec 2021 value amounting to $48.5 million.

  • Black Diamond Therapeutics' Change in Acquisitions & Divestments fell 33.71% to $48.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $182.8 million, marking a year-over-year change of. This contributed to the annual value of $139.8 million for FY2024, which is 78.77% up from last year.
  • According to the latest figures from Q4 2021, Black Diamond Therapeutics' Change in Acquisitions & Divestments is $48.5 million, which was up 23.75% from $39.2 million recorded in Q3 2021.
  • Over the past 5 years, Black Diamond Therapeutics' Change in Acquisitions & Divestments peaked at $73.2 million during Q4 2020, and registered a low of $17.8 million during Q3 2020.
  • Its 2-year average for Change in Acquisitions & Divestments is $45.6 million, with a median of $46.8 million in 2021.
  • Within the past 5 years, the most significant YoY rise in Black Diamond Therapeutics' Change in Acquisitions & Divestments was 120.62% (2021), while the steepest drop was 33.71% (2021).
  • Black Diamond Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $73.2 million in 2020, then crashed by 33.71% to $48.5 million in 2021.
  • Its Change in Acquisitions & Divestments was $48.5 million in Q4 2021, compared to $39.2 million in Q3 2021 and $50.1 million in Q2 2021.